Sector Chart Scholar Rock Holding Corporation
Stocks
SRRK
US80706P1030
Biotechnology & Medical Research
|
Market Closed -
Nasdaq
16:00:00 2026-09-28 EDT
|
5-day change | 1st Jan Change | ||
| 49.13 USD | +1.03% |
|
+2.01% | +11.53% |
| 09-25 | Scholar Rock Poised for De-risked Commercial Ramp in Neuromuscular Space, Wedbush Says | MT |
| 09-24 | Truist Lifts Price Target on Scholar Rock Holding to $77 From $76, Keeps Buy Rating | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Bio Therapeutic Drugs
| Capi. | Sales Growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 5.92B | - | - | - | - | - |
| 72.26B | |||||
| 60.24B | |||||
| 27.73B | |||||
| 25.73B | - | ||||
| 24.75B | - |
Select your edition
All financial news and data tailored to specific country editions
